LONDON (Alliance News) - Ultrasound software and simulation company MedaPhor Group PLC said Thursday that the group's trading was "in line with expectations".
In his annual general meeting statement, Chairman Riccardo Pigliucci said the company's simulation division sales in the UK and Europe showed good signs of recovery.
"The group is trading in line with management's expectations, research and development work being undertaken by our clinical division is progressing well and simulation division sales in the UK and mainland Europe are showing good signs of recovery," he added.
Pigliucci said that initial orders for the newly-launched BodyWorks point of care and emergency medicine simulator were encouraging.
MedaPhor shares were trading up 1.8% at 8.65 pence.